H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description A detailed description of the company s operations and business divisions. - Corporate strategy Analyst s summarization of the company s business strategy. - SWOT Analysis A detailed analysis of the company s strengths, weakness, opportunities and threats. - Company history Progression of key events associated with the company. - Major products and services A list of major products, services and brands of the company. - Key competitors A list of key competitors to the company. - Key employees A list of the key executives of the company. - Executive biographies A brief summary of the executives employment history. - Key operational heads A list of personnel heading key departments/functions. - Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history. Highlights H. Lundbeck A/S (Lundbeck) is a pharmaceutical company, which focuses on enhancing the quality of life of people suffering from brain diseases. The company carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of to the central nervous system (CNS) related diseases. Its products are used in the treatment of diseases such as depression, anxiety, psychotic diseases, alcohol dependence, epilepsy and Huntington s disease, Alzheimer s disease and Parkinson s disease. Lundbeck has production and research facilities in China, Denmark, France, Italy and the US. It operates through its subsidiaries and markets its products across the world. The company is a subsidiary of The Lundbeck Foundation. Lundbeck is headquartered in Valby, Denmark. H. Lundbeck AS Key Recent Developments 3

Sep 09, 2015: GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members Aug 19, 2015: Major restructuring to regain profitability and ensure value creation Aug 07, 2015: Lundbeck Joins Innovative Alzheimer s Disease Research Initiative May 06, 2015: H. Lundbeck: Solid performance in the first quarter of the year May 06, 2015: Kare Schultz appointed new president and CEO of Lundbeck Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company Additional Details Publisher : Global Data Reference : GDPH29835FSA Number of Pages : 69 Report Format : PDF 4

Publisher Information : 5

Table Of Contents for H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents 2List of Tables 4List of Figures 5Section 1 - About the Company 6H. Lundbeck A/S - Key Facts 6H. Lundbeck A/S - Key Employees 7H. Lundbeck A/S - Key Employee Biographies 8H. Lundbeck A/S - Major Products and Services 9H. Lundbeck A/S - Pharmaceutical Pipeline Products Data 10H. Lundbeck A/S, Pipeline Products by Therapy Area 10H. Lundbeck A/S, Pipeline Products by Development Phase 11H. Lundbeck A/S - History 13H. Lundbeck A/S - Company Statement 19H. Lundbeck A/S - Locations And Subsidiaries 20Head Office 20Other Locations & Subsidiaries 20Section 2 Company Analysis 23H. Lundbeck A/S - Business Description 23H. Lundbeck A/S - Corporate Strategy 24H. Lundbeck A/S - SWOT Analysis 25SWOT Analysis - Overview 25H. Lundbeck A/S - Strengths 25Strength - Leading Position - Depression 25Strength - Sturdy Research and Development Activities 25H. Lundbeck A/S - Weaknesses 26Weakness - Product Discontinuations 26Weakness - Operational Performance 26H. Lundbeck A/S - Opportunities 27Opportunity - Pipeline Products 27Opportunity - Product Launches 27Opportunity - Acquisition - Chelsea Therapeutics 27H. Lundbeck A/S - Threats 28Threat - Cost Containment Pressures 28Threat - Intense Competition 28Threat - Stringent Government Regulations 28H. Lundbeck A/S - Key Competitors 29Section 3 Company Financial Ratios 30Financial Ratios - Capital Market Ratios 30Financial Ratios - Annual Ratios 31Performance Chart 33Financial Performance 33Financial Ratios - Interim Ratios 34Financial Ratios - Ratio Charts 35Section 4 Company s Lifesciences Financial Deals and Alliances 36H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 36H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 37H. Lundbeck A/S, Recent Deals Summary 38Section 5 Company s Recent Developments 39Sep 09, 2015: GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members 39Aug 19, 2015: Major restructuring to regain profitability and ensure value creation 40Aug 07, 2015: Lundbeck Joins Innovative Alzheimer s Disease Research Initiative 42May 06, 2015: H. Lundbeck: Solid performance in the first quarter of the year 43May 06, 2015: Kare Schultz appointed new president and CEO of Lundbeck 51Apr 14, 2015: Lundbeck and Keep Memory Alive Invest to Support Multiple System Atrophy Research and Global Taskforce 52Dec 22, 2014: Lundbeck to research link between immune system and brain diseases 54Nov 24, 2014: Ulf Wiinberg Resigns As CEO Of Lundbeck 55Nov 05, 2014: Solid growth of New Products, positive pipeline development and financial outlook maintained 56Aug 07, 2014: Continued solid growth of 36% in New Products - now contributing 27% of revenue 61Section 6 Appendix 65Methodology 65Ratio Definitions 65About GlobalData 69Contact Us 69Disclaimer 69 6

List Of Tables in H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review List of Tables H. Lundbeck A/S, Key Facts 6 H. Lundbeck A/S, Key Employees 7 H. Lundbeck A/S, Key Employee Biographies 8 H. Lundbeck A/S, Major Products and Services 9 H. Lundbeck A/S, Number of Pipeline Products by Therapy Area 10 H. Lundbeck A/S, Number of Pipeline Products by Development Stage 11 H. Lundbeck A/S, Pipeline Products By Therapy Area and Development Phase 12 H. Lundbeck A/S, History 13 H. Lundbeck A/S, Subsidiaries 20 H. Lundbeck A/S, Key Competitors 29 H. Lundbeck A/S, Ratios based on current share price 30 H. Lundbeck A/S, Annual Ratios 31 H. Lundbeck A/S, Interim Ratios 34 H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 36 H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 37 H. Lundbeck A/S, Recent Deals Summary 38 Currency Codes 65 Capital Market Ratios 65 Equity Ratios 66 Profitability Ratios 66 Cost Ratios 67 Liquidity Ratios 67 Leverage Ratios 68 Efficiency Ratios 68 7

List Of Figures, Charts and Diagrams in H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review List of Figures H. Lundbeck A/S, Pipeline Products by Therapy Area 10 H. Lundbeck A/S, Pipeline Products by Development Phase 11 H. Lundbeck A/S, Performance Chart (2010-2014) 33 H. Lundbeck A/S, Ratio Charts 35 H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 36 H. Lundbeck A/S, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 37 8

How to Buy... H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $125 Single User Price $250 Site License Price $375 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9